IRIS UniCatt

Mazzone, Elena Stacy
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 598
NA - Nord America 573
AS - Asia 401
SA - Sud America 105
AF - Africa 9
Totale 1.686
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 555
IT - Italia 206
SG - Singapore 148
CN - Cina 115
BR - Brasile 91
SE - Svezia 79
DE - Germania 72
FR - Francia 54
IE - Irlanda 48
ID - Indonesia 38
FI - Finlandia 28
RU - Federazione Russa 27
KR - Corea 24
GB - Regno Unito 21
IN - India 17
NL - Olanda 15
HK - Hong Kong 12
CA - Canada 10
TR - Turchia 10
PE - Perù 7
IL - Israele 6
PL - Polonia 6
AT - Austria 5
CO - Colombia 5
ES - Italia 5
JP - Giappone 5
CH - Svizzera 4
CZ - Repubblica Ceca 4
IR - Iran 4
UA - Ucraina 4
VN - Vietnam 4
BD - Bangladesh 3
DK - Danimarca 3
EG - Egitto 3
PA - Panama 3
BE - Belgio 2
GR - Grecia 2
HR - Croazia 2
JM - Giamaica 2
LT - Lituania 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
TH - Thailandia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AM - Armenia 1
AR - Argentina 1
BG - Bulgaria 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
IQ - Iraq 1
KE - Kenya 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
PH - Filippine 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
VE - Venezuela 1
Totale 1.686
Salva come PNG Salva come JPEG
Città #
Singapore 109
Chandler 108
Ashburn 86
New York 51
Dublin 40
Jakarta 37
Rome 32
Milan 29
Hefei 27
Seoul 24
Munich 20
Los Angeles 19
Helsinki 17
Moscow 14
Palermo 14
Frankfurt am Main 11
Nuremberg 11
Chicago 10
Düsseldorf 10
Hong Kong 10
Marseille 10
Pune 10
Turku 10
Princeton 8
Boston 7
Lima 7
San Mateo 7
Santa Clara 7
São Paulo 7
Columbus 6
Falkenstein 6
Florence 6
Lauterbourg 5
London 5
Naples 5
San Francisco 5
Secaucus 5
Toronto 5
Turin 5
Ancona 4
Edinburgh 4
Fairfield 4
Kiel 4
Shenzhen 4
Tokyo 4
Wilmington 4
Amsterdam 3
Bern 3
Brasília 3
Bremen 3
Brno 3
Bucaramanga 3
Busto Arsizio 3
Council Bluffs 3
Hangzhou 3
Harrisburg 3
Istanbul 3
Triggiano 3
Wroclaw 3
Antalya 2
Athens 2
Atlanta 2
Barbarano Vicentino 2
Beijing 2
Bergamo 2
Boardman 2
Bologna 2
Brussels 2
Buffalo 2
Cairo 2
Campinas 2
Conegliano 2
Copenhagen 2
Genoa 2
Goiânia 2
Ho Chi Minh City 2
Hyderabad 2
Johannesburg 2
Kazan' 2
Kolkata 2
Las Vegas 2
Maricá 2
Menlo Park 2
Modena 2
Nus 2
Oegstgeest 2
Panama City 2
Perafita 2
Pescara 2
Piacenza 2
Portsmouth 2
Priolo Gargallo 2
Redmond 2
Roubaix 2
Royal Oak 2
Salvador 2
San Martino in Rio 2
Sandston 2
Shanghai 2
Springfield 2
Totale 954
Salva come PNG Salva come JPEG
Nome #
Performance of Upper Limb module for Duchenne muscular dystrophy 169
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 111
Different trajectories in upper limb and gross motor function in spinal muscular atrophy 93
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial 80
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 71
Clinical Variability in Spinal Muscular Atrophy Type III. 66
Revised upper limb module in type II and III spinal muscular atrophy: 24-month changes 65
Our Experience on Temporal Bone Fractures: Retrospective Analysis of 141 Cases 61
Revised upper limb module for spinal muscular atrophy: Development of a new module 58
North Star Ambulatory Assessment changes in ambulant Duchenne boys amenable to skip exons 44, 45, 51, and 53: A 3 year follow up 55
2-Year Change in Revised Hammersmith Scale Scores in a Large Cohort of Untreated Paediatric Type 2 and 3 SMA Participants 51
Sleep disorders in spinal muscular atrophy 50
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 47
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 46
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 46
First international workshop on rehabilitation management and clinical outcome measures for spinal muscular atrophy 45
Patterns of disease progression in type 2 and 3 SMA: Implications for clinical trials 43
Gain and loss of upper limb abilities in Duchenne muscular dystrophy patients: A 24-month study 43
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo-controlled, dose-finding trial followed by 24 months of treatment 41
Old measures and new scores in spinal muscular atrophy patients 39
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 38
Emergencies cards for neuromuscular disorders 1st Consensus Meeting from UILDM - Italian Muscular Dystrophy Association Workshop report 37
Early neurodevelopmental assessment in Duchenne muscular dystrophy 34
Erratum: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-month changes (PLoS ONE (2015) 10:12 (e0144079)) 33
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy 33
Patient reported outcome measure for upper limb in Duchenne muscular dystrophy: correlation with PUL2.0 32
Longitudinal Analysis of PUL 2.0 Domains in Ambulant and Non-Ambulant Duchenne Muscular Dystrophy Patients: How do they Change in Relation to Functional Ability? 30
Hammersmith Functional Motor Scale and Motor Function Measure-20 in non ambulant SMA patients 25
Revised Hammersmith Scale for spinal muscular atrophy: A SMA specific clinical outcome assessment tool 23
Assessing upper limb function in nonambulant SMA patients: Development of a new module 22
The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability 21
Correction: Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 (PLoS ONE (2019) 14:6 (e0218683) DOI: 10.1371/journal.pone.0218683) 20
Spinal muscular atrophy functional composite score: A functional measure in spinal muscular atrophy 18
Daily salbutamol in young patients with SMA type II 16
Development of a patient-reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM 16
Correction to: Two‑year efficacy and safety of risdiplam in patients with type 2 or non‑ambulant type 3 spinal muscular atrophy (SMA) 15
Correction: Long term natural history data in ambulant boys with duchenne muscular dystrophy: 36-Month changes 13
Reliability of the North Star Ambulatory Assessment in a multicentric setting 12
Totale 1.718
Salva come PNG Salva come JPEG
Categoria #
all - tutte 11.020
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.020
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 0 0 0 0 1 1 0
2021/202293 11 0 0 19 4 6 3 10 4 6 18 12
2022/2023359 19 30 26 44 30 59 17 34 51 12 20 17
2023/2024467 22 83 12 23 15 87 40 43 11 21 50 60
2024/2025797 22 15 82 25 60 53 47 34 82 69 209 99
Totale 1.718